Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Sudden death with no other explanation/Sudden death; Fall; Fatigue; fleeting thoracic D+/chest pain; Myalgia; Fever; shivering; Malaise; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority (RA)-WEB, regulatory authority number BE-FAMHP-DHH-N2021-91187. A 48-year-old male patient received first dose of BNT162B2 (COMIRNATY), via an unspecified route of administration on 01May2021 (Batch/Lot Number: EX2405) as single dose for covid-19 immunisation. Medical history included tobacco. Concomitant medications included pregabalin (LYRICA) and tramadol hydrochloride (TRADONAL). On 03May2021, patient experienced fever, malaise, shivering, fatigue, myalgia, fall, chest pain, on 07May2021, patient experienced sudden death. Events was further described as follows: Sudden death with no other explanation, malaise, fall and death, failure to attend on 07May2021. No visible cause of death, no known vascular disease, general malaise since Monday 03May2021, did not consult (fleeting thoracic D+ on 03May2021, lasting about 1h, took Dafalgan 1g). For events fever, malaise, shivering, fatigue, myalgia, fall, sudden death, there was no treatment. The outcome of the events was fatal. The patient died on 07May2021. An autopsy was not performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: fleeting thoracic D+/chest pain; Myalgia; Fever; Sudden death with no other explanation/Sudden death; Fall; Shivering; Malaise; Fatigue
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166